What is the share price of Ngl Fine Chem Ltd (NGLFINE) today?
The share price of NGLFINE as on 21st September 2026 is ₹2731.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ngl Fine Chem Ltd (NGLFINE) share?
The past returns of Ngl Fine Chem Ltd (NGLFINE) share are- Past 1 week: 2.53%
- Past 1 month: -9.67%
- Past 3 months: -10.60%
- Past 6 months: 33.59%
- Past 1 year: 91.96%
- Past 3 years: 38.17%
- Past 5 years: 46.16%
What are the peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE)?
The peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE) include:What is the dividend yield % of Ngl Fine Chem Ltd (NGLFINE) share?
The current dividend yield of Ngl Fine Chem Ltd (NGLFINE) is 0.06.What is the market cap of Ngl Fine Chem Ltd (NGLFINE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ngl Fine Chem Ltd (NGLFINE) is ₹1710.20 Cr as of 21st September 2026.What is the 52 week high and low of Ngl Fine Chem Ltd (NGLFINE) share?
The 52-week high of Ngl Fine Chem Ltd (NGLFINE) is ₹3602 and the 52-week low is ₹1271.What is the PE and PB ratio of Ngl Fine Chem Ltd (NGLFINE) stock?
The P/E (price-to-earnings) ratio of Ngl Fine Chem Ltd (NGLFINE) is 35.54. The P/B (price-to-book) ratio is 5.19.Which sector does Ngl Fine Chem Ltd (NGLFINE) belong to?
Ngl Fine Chem Ltd (NGLFINE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ngl Fine Chem Ltd (NGLFINE) shares?
You can directly buy Ngl Fine Chem Ltd (NGLFINE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ngl Fine Chem Ltd
NGLFINE Share Price
NSENGLFINE Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NGLFINE Performance & Key Metrics
NGLFINE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 29.90 | 5.19 | 0.06% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.26 | 5.93 | 0.48% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
NGLFINE Company Profile
NGL Fine-Chem Limited is manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.
NGLFINE Sentiment Analysis
NGLFINE Sentiment Analysis
NGLFINE Stock Summary · May 2026
Management framed Q4 and FY26 as a clear recovery, citing Q4 revenue of ₹149.23 crore (up 57% YoY) and FY26 revenue of ₹500.95 crore (up 36% YoY) as evidence of materially stronger performance. They emphasized operational execution—Phase I is live and running at ~70–80% utilization while Phase II’s commissioning slipped to early Q2 FY27 with commercial production targeted in H2 FY27—and prioritized completing a ₹210 crore expansion (₹182.75 crore spent through Q4, ~₹15–20 crore more expected) alongside increased outsourcing to lift volumes. Management highlighted regulatory progress with multiple VMS filings and ongoing CEP/DMS approvals to support European and US‑regulated market entry, but acknowledged inspection timing could delay meaningful US revenues until FY2028 and that Phase‑2 capacity may serve ROW/Europe in the interim. They noted margin pressure from freight, raw materials and forex yet reiterated a 15%–18% EBITDA target and expected price pass‑through to begin improving margins from Q2, targeting a new quarterly revenue run‑rate above ₹150 crore while funding expansion from internal cash and keeping debt at roughly ₹100 crore.
NGLFINE Stock Growth Drivers
NGLFINE Stock Growth Drivers
6Material financial recovery and improved profitability
FY26 marked a clear recovery with materially stronger top- and bottom-line results: full-year revenue rose
Capacity expansion translating into higher volumes and near‑term scaling
Phase I of the expansion is operational and has absorbed higher volumes this quarter, with
NGLFINE Stock Challenges
NGLFINE Stock Challenges
6Input-cost and forex-driven margin compression
The company experienced material margin pressure during the quarter driven by geopolitical-driven freight and raw-material
Expansion execution delays and higher-than-expected CAPEX with limited near-term revenue upside
Phase II at Tarapur faced construction delays due to gas and labour shortages that pushed
NGLFINE Forecast
NGLFINE Forecasts
Price
Revenue
Earnings
NGLFINE Company Revenue Forecast
NGLFINE Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
NGLFINE Stock EPS (Earnings Per Share) Forecast
NGLFINE Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
NGLFINE
NGLFINE
Income
Balance Sheet
Cash Flow
NGLFINE Income Statement
NGLFINE Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 103.44 | 96.64 | 98.60 | 88.97 | 94.01 | 110.54 | 122.31 | 132.12 | 151.69 | 146.59 | ||||||||||
| Operating & Other expenses | 83.94 | 81.40 | 81.93 | 84.00 | 88.65 | 93.21 | 103.10 | 105.20 | 127.82 | 115.88 | ||||||||||
| EBITDA | 19.50 | 15.24 | 16.67 | 4.97 | 5.36 | 17.33 | 19.21 | 26.92 | 23.87 | 30.71 | ||||||||||
| Depreciation/Amortization | 2.92 | 3.00 | 3.03 | 3.10 | 3.32 | 4.27 | 5.09 | 5.18 | 5.05 | 5.25 | ||||||||||
| PBIT | 16.58 | 12.24 | 13.64 | 1.87 | 2.04 | 13.06 | 14.12 | 21.74 | 18.82 | 25.46 | ||||||||||
| Interest & Other Items | 0.49 | 0.44 | 0.32 | 0.60 | 0.97 | 1.22 | 1.16 | 1.07 | 1.01 | 0.99 | ||||||||||
| PBT | 16.09 | 11.80 | 13.32 | 1.27 | 1.07 | 11.84 | 12.96 | 20.67 | 17.81 | 24.47 | ||||||||||
| Taxes & Other Items | 3.77 | 2.57 | 3.52 | -0.01 | 0.52 | 2.60 | 3.34 | 4.98 | 4.32 | 6.08 | ||||||||||
| Net Income | 12.32 | 9.23 | 9.80 | 1.28 | 0.55 | 9.24 | 9.62 | 15.69 | 13.49 | 18.39 | ||||||||||
| EPS | 19.95 | 14.92 | 15.88 | 2.07 | 0.88 | 14.96 | 15.58 | 25.40 | 21.83 | 29.78 |
NGLFINE Company Updates
Investor Presentation
NGLFINE Stock Peers
NGLFINE Past Performance & Peer Comparison
NGLFINE Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ngl Fine Chem Ltd | 35.54 | 5.19 | 0.06% |
| Sun Pharmaceutical Industries Ltd | 38.40 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 85.10 | 10.47 | 0.70% |
| Zydus Lifesciences Ltd | 22.96 | 3.91 | 0.09% |
NGLFINE Stock Price Comparison
Compare NGLFINE with any stock or ETFNGLFINE Holdings
NGLFINE Shareholdings
NGLFINE Promoter Holdings Trend
NGLFINE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
NGLFINE Institutional Holdings Trend
NGLFINE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
NGLFINE Shareholding Pattern
NGLFINE Shareholding Pattern
NGLFINE Shareholding History
NGLFINE Shareholding History
smallcases containing NGLFINE stock
smallcases containing NGLFINE stock
Looks like this stock is not in any smallcase yet.
NGLFINE Events
NGLFINE Events
NGLFINE Dividend Trend
NGLFINE has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.06%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.63 every year
Dividends
Corp. Actions
Announcements
Legal Orders
NGLFINE Dividend Trend
NGLFINE has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.06%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.63 every year
NGLFINE Upcoming Dividends
NGLFINE Upcoming Dividends
No upcoming dividends are available
NGLFINE Past Dividends
NGLFINE Past Dividends
Cash Dividend
Ex DateEx DateAug 18, 2026
Dividend/Share
₹1.75
Ex DateEx Date
Aug 18, 2026
Cash Dividend
Ex DateEx DateAug 12, 2025
Dividend/Share
₹1.75
Ex DateEx Date
Aug 12, 2025
Cash Dividend
Ex DateEx DateAug 16, 2024
Dividend/Share
₹1.75
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateAug 18, 2023
Dividend/Share
₹1.75
Ex DateEx Date
Aug 18, 2023
Cash Dividend
Ex DateEx DateJun 22, 2022
Dividend/Share
₹1.75
Ex DateEx Date
Jun 22, 2022
NGLFINE Stock News & Opinions
NGLFINE Stock News & Opinions
NGL Fine-Chem announced that the 45th Annual General Meeting(AGM) of the company will be held on 25 August 2026.
NGL Fine-Chem announced that the Board of Directors of the Company at its meeting held on 21 May 2026, inter alia, have recommended the final dividend of Rs 1.75 per equity Share (i.e. 35%) , subject to the approval of the shareholders.
Net profit of NGL Fine Chem rose 2398.15% to Rs 13.49 crore in the quarter ended March 2026 as against Rs 0.54 crore during the previous quarter ended March 2025. Sales rose 57.13% to Rs 149.23 crore in the quarter ended March 2026 as against Rs 94.97 crore during the previous quarter ended March 2025. For the full year,net profit rose 127.89% to Rs 48.13 crore in the year ended March 2026 as against Rs 21.12 crore during the previous year ended March 2025. Sales rose 36.03% to Rs 500.95 crore in the year ended March 2026 as against Rs 368.26 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales149.2394.97 57 500.95368.26 36 OPM %14.356.65 -14.519.20 - PBDT22.864.38 422 82.9540.17 106 PBT17.811.06 1580 63.3727.71 129 NP13.490.54 2398 48.1321.12 128 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 21 May 2026.
NGL Fine Chem announced that CRISIL Ratings has revised its outlook on the long-term bank loan facilities of the Company to 'Stable' from 'Negative' while reaffirming the rating at 'Crisil BBB+'. The short term rating has been reaffirmed at 'Crisil A2'.Powered by Capital Market - Live
Net profit of NGL Fine Chem rose 1125.78% to Rs 15.69 crore in the quarter ended December 2025 as against Rs 1.28 crore during the previous quarter ended December 2024. Sales rose 43.11% to Rs 127.51 crore in the quarter ended December 2025 as against Rs 89.10 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales127.5189.10 43 OPM %17.505.71 - PBDT25.854.36 493 PBT20.671.27 1528 NP15.691.28 1126 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live
Net profit of NGL Fine Chem declined 1.83% to Rs 9.63 crore in the quarter ended September 2025 as against Rs 9.81 crore during the previous quarter ended September 2024. Sales rose 28.65% to Rs 120.26 crore in the quarter ended September 2025 as against Rs 93.48 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales120.2693.48 29 OPM %14.2712.36 - PBDT18.0516.36 10 PBT12.9613.33 -3 NP9.639.81 -2 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
Net profit of NGL Fine Chem rose 0.22% to Rs 9.24 crore in the quarter ended June 2025 as against Rs 9.22 crore during the previous quarter ended June 2024. Sales rose 14.81% to Rs 104.19 crore in the quarter ended June 2025 as against Rs 90.75 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales104.1990.75 15 OPM %10.5410.31 - PBDT16.1114.79 9 PBT11.8411.79 0 NP9.249.22 0 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 14.16%, vs industry avg of 11.76%
Over the last 5 years, market share increased from 0.09% to 0.1%
Over the last 5 years, net income has grown at a yearly rate of -3.24%, vs industry avg of 10.45%